Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.5 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.5 | 0.5 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.5 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.5 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.5 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.5 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0019 | 0.5 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.5 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.5 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.5 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.5 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.5 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.5 | 0.5 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.3294 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.